Anal Sexually Transmitted Infections and Risk of HIV Infection in Homosexual Men

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst, New South Wales 2010, Australia.
JAIDS Journal of Acquired Immune Deficiency Syndromes (Impact Factor: 4.56). 10/2009; 53(1):144-9. DOI: 10.1097/QAI.0b013e3181b48f33
Source: PubMed


We examined a range of common bacterial and viral sexually transmitted infections as risk factors for HIV seroconversion in a community-based cohort of HIV-negative homosexual men in Sydney, Australia.
Detailed information about HIV risk behaviors was collected by interview twice yearly. Participants were tested annually for HIV, anal and urethral gonorrhea and chlamydia, herpes simplex virus types 1 and 2, and syphilis. In addition, they reported annual diagnoses of these conditions and of genital and anal warts.
Among 1427 enrolled participants, 53 HIV seroconverters were identified, giving an incidence of 0.78 per 100 person-years. After controlling for number of episodes of insertive and receptive nonseroconcordant unprotected anal intercourse, there were independent associations with anal gonorrhea (adjusted hazard ratio = 7.12, 95% confidence interval: 2.05 to 24.79) and anal warts (hazard ratio = 3.63, 95% confidence interval: 1.62 to 8.14).
Anal gonorrhea and anal warts were independently associated with HIV acquisition. The added HIV prevention value of more frequent screening of the anus to allow early detection and treatment of anal sexually transmitted infections in homosexual men should be considered.

14 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: For the first time, both GAA and bulk devices were shown to be operational on the same chip. Not all issues have been solved yet (gate materials, access resistance) but already the first-try results are very encouraging: I<sub>on</sub>=170 μA/μm@1.2 V and gate oxide of 20 Å. Thanks to the GAA intrinsic immunity to SCE, its DIBL was as small as 10 mV compared with 600 mV on bulk control devices. Calibrating a 2D simulator on this electrical data, the performance of the GAA was estimated to be at least 1500 μA/μm@ 1 V with comfortable gate oxide of 20 Å, once having corrected for the large R<sub>access</sub> (∼3000 Ω), that was simply due to non-optimal mask layout used in this first device realization.
    VLSI Technology, 2002. Digest of Technical Papers. 2002 Symposium on; 02/2002
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study was to assess whether subpopulations with sufficiently high HIV incidences for HIV prevention trials can be identified in low HIV incidence settings such as Australia. In a community-based cohort study of HIV-negative homosexually active men in Sydney, Australia, potential risk factors associated with an annual HIV incidence of ≥2 per 100 person-years (PY) were identified. A stepwise procedure ranked these factors according to HIV incidence, to create a 'high-incidence' subgroup of participants. Willingness to participate in HIV prevention trials was assessed. Although the incidence in the cohort overall was only 0.78 per 100 PY, nine risk variables were associated with an HIV incidence of 2 per 100 PY or greater. Stepwise inclusion of these variables revealed a 'high-incidence' subgroup of men representing 24% of the total follow-up time with a combined HIV incidence of 2.71 per 100 PY, who reported at least one of three risk factors in the past 6 months. These men were more willing than others to participate in vaccine and antiretroviral therapy HIV prevention trials. These findings demonstrate that it is possible to identify high HIV incidence subpopulations in low-incidence settings such as Australia, and these men are of above average willingness to participate in HIV prevention trials.
    HIV Medicine 04/2010; 11(10):635-41. DOI:10.1111/j.1468-1293.2010.00833.x · 3.99 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: We review recent evidence about the link between sexually transmitted infections (STI) and HIV transmission and consider implications for control programmes. New studies and meta-analyses confirm the association of HIV acquisition and transmission with recent STIs, although there is considerable heterogeneity between organisms and populations. Much of the recent evidence relates to herpes simplex virus type 2 (HSV-2), for which the population-attributable risk percentage (PAR%) for HSV-2 is between 25 and 35 in Africa. Mathematical models show how transmission attributable to STI varies with HIV epidemic phase, and HSV-2 becomes increasingly important as the epidemic matures. HSV-2 suppressive therapy reduces HIV concentrations in plasma and the genital tract in people coinfected with HSV-2, in part due to direct inhibition of HIV reverse transcriptase. Recent trials of HSV-2 suppressive therapy have not shown an impact on the risk of HIV acquisition, nor in controlling transmission from dually infected people to their serodiscordant heterosexual partners. Although there is a plausible link between STI and HIV risk, intervention studies continue to be disappointing. This fact does not disprove a causal link, but mechanisms of action and the design and implementation of interventions need to be better understood.
    Current opinion in HIV and AIDS 07/2010; 5(4):305-10. DOI:10.1097/COH.0b013e32833a8844 · 4.68 Impact Factor
Show more

Similar Publications